Press Release

Surrogacy Market Size will be propelled by Increasing Number of Infertility Cases

Date : Dec 27, 2022

Global Surrogacy Market size is expected to be worth roughly USD 11.4 billion by 2030, growing at a CAGR of more than 6.7% during the projected timeframe of 2022-2030, according to Ameco Research

Surrogacy is an assisted reproductive techniques technique in which the prospective parents collaborate with a surrogate who delivers the baby till birth. Traditional and gestational surrogacies are the two forms of assisted reproductive treatments employed. The traditional method uses a surrogate's eggs, giving them the actual mom of the baby. During pregnancy, the surrogate has no genetic relationship with the baby. The increase in the number of individuals who suffer from infertility issues such as low sperm concentration and difficulties with egg and sperm synthesis is a major factor driving the surrogacy market growth. The increase in fertility problems is caused by factors including hormonal fluctuations, stress, alcohol usage, and steroid use, which has a beneficial effect on business growth.

The demand for surrogacy procedures is expected to rise in the next years as a result of increased habits among both men and women, such as smoking, drunkenness, and the intake of calorie-rich diets, all of which have an impact on conception rates. Because of such poor lifestyle choices, the capacity to bear a child is suffering, leading to a rise in the number of infertility disorders. Due to the globalization of fertility challenges, healthcare organizations are increasing their efforts in infertility treatment in order to give technologically improved possibilities including such surrogates that can help couples have children.

Request for a sample of this premium research report @ https://www.amecoresearch.com/sample/276758

Global Surrogacy Market Trends  

Rising scientific developments in assisted reproductive techniques, as well as increasing public awareness of infertility problems such as egg or sperm transfer and in-vitro fertilization (IVF), are propelling the surrogacy market size. Furthermore, the incidence of polycystic ovarian syndrome (PCOS) in women is increasing due to stress, decreased physical activity, hormonal imbalance, as well as lifestyle changes such as smoking, drunkenness, and excessive intake of calorie-rich foods. This, together with the increasing amount of fertility clinics all around the world, is having a favorable impact on the surrogacy market value. Aside from that, surrogacy specialists are increasingly using gestational surrogacy because it is less complicated than traditional surrogacy.

Furthermore, the increasing healthcare business provides market participants with significant growth potential. These companies are also working on acquisitions and mergers and partnerships in order to grow their present consumer base and improve the profitability of the company. Other reasons driving market expansion include increased fertility tourists, increased inability to produce, the accessibility of capital surrogacy, and attractive reimbursement policies granted by regulatory bodies in a number of countries.

Surrogacy Market Segmentation                           

Ameco Research has fragmented the global surrogacy market by mode of type, technology, age group, and end user. By mode of type, the industry is sub-divided into gestational surrogacy, and traditional surrogacy. Gestational surrogacy led the worldwide market in 2021 and is expected to maintain this tendency during the projected timeframe, owing to surrogacy experts' increased adoption of gestational procedures as well as technical improvements. Furthermore, surrogacy specialists' increased usage of gestational procedures, combined with technological developments, is likely to boost the surrogacy market shares. Moreover, the psychological and legal challenges of traditional surrogacy encourage the use of gestational surrogacy.

In term of technology, the market is classified into in-vitro fertilization (IVF), intrauterine insemination (IUI) (intracytoplasmic sperm injection (ICSI) and classical/standard IVF), and others. Moreover, the market is split into below 35 years, 35-37 years, 38 - 39 years, 40-42 years, 43-44 years, and over 44 years, based on age group.

Based on the end user, the market is divided into fertility clinics, hospitals, and others. According to the surrogacy market forecast, the fertility clinics sector segment is expected to grow extensively in the global market over the next few years.

Surrogacy Market Regional Outlook        

The global surrogacy market is divided into several geographical regions: North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa. According to surrogacy industry analysis, Europe is the market's dominant region. Due to variables including the region's reliable healthcare infrastructure, which enables the use of cutting-edge technology-based treatments, players are obtaining lucrative opportunities in the Europe surrogacy market.

Asia-Pacific is among the fastest-growing regions in the surrogacy market. The rising incidence of fertility-related disorders, growing consumer spending on the number of inhabitants, the availability of advanced medical technologies, as well as the presence of a significant number of important players in the region are all contributing to the expansion of the Asia-Pacific surrogacy market revenue.

Surrogacy Market Market Companies                              

Some of the most notable worldwide surrogacy market players are Bourn Hall Fertility Clinic, Scanfert AVA Clinic, Nova IVI Fertility, Max Healthcare, Bangkok IVF Center, Cardone & Associates Reproductive Medicine & Infertility, LLC, IVI-RMA Global, Ovation Fertility, Extraordinary Conceptions, New Hope Fertility Center, and Growing Generations, LLC.

To receive personalized service, please share your research needs here@ https://www.amecoresearch.com/enquiry-before-buy/276758

Buy this premium research report - https://www.amecoresearch.com/buy/276758

Contact Us:

Mr. Richard

Ameco Research

USA: +1 347 474 3864

India: +91 8983225533

E-mail: sales@amecoresearch.com